Analysts expect that HCA Healthcare Inc (NYSE:HCA) will post earnings per share of $2.49 for the current fiscal quarter, Zacks reports. Ten analysts have provided estimates for HCA Healthcare’s earnings, with estimates ranging from $2.36 to $2.70. HCA Healthcare posted earnings of $2.29 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 8.7%. The company is expected to announce its next earnings report before the market opens on Tuesday, July 30th.

According to Zacks, analysts expect that HCA Healthcare will report full year earnings of $10.40 per share for the current fiscal year, with EPS estimates ranging from $10.01 to $10.80. For the next fiscal year, analysts anticipate that the company will post earnings of $11.22 per share, with EPS estimates ranging from $10.49 to $11.71. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The business had revenue of $12.52 billion during the quarter, compared to analyst estimates of $12.34 billion. During the same quarter in the previous year, the business earned $3.18 earnings per share. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year.

Several research analysts have issued reports on HCA shares. Barclays set a $24.00 target price on Tenet Healthcare and gave the company a “hold” rating in a research report on Wednesday, April 17th. Zacks Investment Research upgraded GALP ENERGIA SG/ADR from a “sell” rating to a “hold” rating in a research report on Monday, May 27th. UBS Group restated a “sell” rating on shares of in a research report on Monday, June 24th. Goldman Sachs Group lowered EXPERIAN PLC/ADR from a “buy” rating to a “neutral” rating in a research report on Wednesday, July 10th. Finally, Deutsche Bank downgraded shares of Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 price target for the company. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and eighteen have given a buy rating to the company’s stock. HCA Healthcare has a consensus rating of “Buy” and an average price target of $152.76.

Shares of NYSE:HCA traded up $3.19 during trading hours on Friday, hitting $145.06. 2,639,435 shares of the company’s stock traded hands, compared to its average volume of 1,147,816. HCA Healthcare has a 1 year low of $110.31 and a 1 year high of $147.42. The firm has a fifty day simple moving average of $134.89. The firm has a market cap of $48.56 billion, a price-to-earnings ratio of 14.85, a P/E/G ratio of 1.21 and a beta of 0.80.

The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Monday, June 3rd were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend was Friday, May 31st. HCA Healthcare’s dividend payout ratio is presently 16.38%.

In related news, insider Jon M. Foster sold 44,281 shares of the business’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the transaction, the insider now owns 96,052 shares of the company’s stock, valued at $11,745,238.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.70% of the company’s stock.

A number of large investors have recently modified their holdings of the stock. Redwood Investments LLC raised its stake in HCA Healthcare by 1.2% in the second quarter. Redwood Investments LLC now owns 50,284 shares of the company’s stock worth $6,797,000 after buying an additional 589 shares in the last quarter. Creative Planning raised its stake in HCA Healthcare by 4.9% in the second quarter. Creative Planning now owns 8,789 shares of the company’s stock worth $1,188,000 after buying an additional 411 shares in the last quarter. Virginia Retirement Systems ET AL raised its stake in HCA Healthcare by 13.6% in the second quarter. Virginia Retirement Systems ET AL now owns 112,600 shares of the company’s stock worth $15,220,000 after buying an additional 13,500 shares in the last quarter. Sumitomo Life Insurance Co. raised its stake in HCA Healthcare by 4.2% in the second quarter. Sumitomo Life Insurance Co. now owns 20,094 shares of the company’s stock worth $2,716,000 after buying an additional 812 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC raised its stake in HCA Healthcare by 2.1% in the second quarter. Steward Partners Investment Advisory LLC now owns 3,940 shares of the company’s stock worth $532,000 after buying an additional 82 shares in the last quarter. 70.18% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: What is the Moving Average Convergence Divergence (MACD) oscillator?

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.